Grace Therapeutics, Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
GRCE Nasdaq 2834 www.gracetx.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Grace Therapeutics, Inc.

Grace Therapeutics to Participate in the H.C. Wainright 28th Annual Global Investment Conference - Sep 3rd, 2026 6:00 am
Grace Therapeutics Announces First Quarter 2027 Financial Results, Provides Business Update - Aug 13th, 2026 6:00 am
Grace Therapeutics Announces $10 Million Private Placement - Aug 4th, 2026 7:00 pm
Grace Therapeutics Announces Receipt of Type A Meeting Minutes from U.S. Food and Drug Administration - Jul 28th, 2026 5:00 am
Grace Therapeutics Announces 2026 Fiscal Year-End Financial Results, Provides Business Update - Jun 18th, 2026 6:00 am
Grace Therapeutics Provides Regulatory Update on New Drug Application for GTx-104 - Apr 23rd, 2026 11:13 am
Grace Therapeutics Announces Abstract Highlighting STRIVE-ON Phase 3 Trial Results Accepted for Presentation at AAN 2026 - Apr 14th, 2026 6:00 am
We're Not Very Worried About Grace Therapeutics' (NASDAQ:GRCE) Cash Burn Rate - Apr 4th, 2026 7:52 am
Grace Therapeutics to Present Data on the Unmet Medical Needs and Potential Benefits of GTx-104 in the Treatment of aSAH at Upcoming Medical Conferences - Mar 19th, 2026 6:00 am
Grace Therapeutics to Participate in the TD Cowen 46th Annual Health Care Conference - Feb 25th, 2026 6:00 am
Grace Therapeutics Announces Third Quarter 2026 Financial Results, Provides Business Update - Feb 12th, 2026 6:00 am
Grace Therapeutics to Participate in 16th Annual Craig-Hallum Alpha Select Conference - Nov 17th, 2025 6:00 am
Grace Therapeutics Announces Second Quarter 2026 Financial Results, Provides Business Update - Nov 13th, 2025 6:00 am
This Grace Therapeutics Insider Increased Their Holding By 12% Last Year - Nov 1st, 2025 8:14 am